Neuroendocrine Aging: Pituitary–Gonadal Axis in Males

[1]  Ali Iranmanesh,et al.  An ensemble model of the male gonadal axis: illustrative application in aging men. , 2006, Endocrinology.

[2]  A. Iranmanesh,et al.  Aging in healthy men impairs recombinant human luteinizing hormone (LH)-stimulated testosterone secretion monitored under a two-day intravenous pulsatile LH clamp. , 2005, The Journal of clinical endocrinology and metabolism.

[3]  J. Veldhuis,et al.  Clinical review 171: The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations. , 2004, The Journal of clinical endocrinology and metabolism.

[4]  D. M. Keenan,et al.  Reconstruction of in vivo time-evolving neuroendocrine dose-response properties unveils admixed deterministic and stochastic elements. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Araujo,et al.  Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. , 2002, The Journal of clinical endocrinology and metabolism.

[6]  D M Keenan,et al.  Hypothesis testing of the aging male gonadal axis via a biomathematical construct. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[7]  E. Metter,et al.  Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. , 2001, The Journal of clinical endocrinology and metabolism.

[8]  D. Grobbee,et al.  Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. , 2000, The Journal of clinical endocrinology and metabolism.

[9]  Mahmoud,et al.  Serum inhibin B levels in community‐dwelling elderly men1 , 2000, Clinical endocrinology.

[10]  A. Iranmanesh,et al.  Two-week pulsatile gonadotropin releasing hormone infusion unmasks dual (hypothalamic and Leydig cell) defects in the healthy aging male gonadotropic axis. , 1999, European journal of endocrinology.

[11]  A. Kriska,et al.  Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants. , 1997, American journal of epidemiology.

[12]  J. Veldhuis,et al.  Specific linkages among luteinizing hormone, follicle-stimulating hormone, and testosterone release in the peripheral blood and human spermatic vein: evidence for both positive (feed-forward) and negative (feedback) within-axis regulation. , 1997, The Journal of clinical endocrinology and metabolism.

[13]  P J Garry,et al.  Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. , 1997, Metabolism: clinical and experimental.

[14]  Steven M. Pincus,et al.  Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[15]  C. Longcope.  The effect of human chorionic gonadotropin on plasma steroid levels in young and old men. , 1973, Steroids.